Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (HKG:2315)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
54.65
+9.47 (20.96%)
At close: Mar 6, 2026

HKG:2315 Statistics

Total Valuation

HKG:2315 has a market cap or net worth of HKD 35.60 billion. The enterprise value is 35.74 billion.

Market Cap 35.60B
Enterprise Value 35.74B

Important Dates

The next confirmed earnings date is Friday, March 27, 2026.

Earnings Date Mar 27, 2026
Ex-Dividend Date n/a

Share Statistics

HKG:2315 has 446.90 million shares outstanding. The number of shares has decreased by -0.31% in one year.

Current Share Class 110.78M
Shares Outstanding 446.90M
Shares Change (YoY) -0.31%
Shares Change (QoQ) -0.38%
Owned by Insiders (%) 14.07%
Owned by Institutions (%) 18.84%
Float 156.77M

Valuation Ratios

The trailing PE ratio is 114.21 and the forward PE ratio is 66.01.

PE Ratio 114.21
Forward PE 66.01
PS Ratio 23.20
PB Ratio n/a
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings 185.44
EV / Sales 23.29
EV / EBITDA 98.08
EV / EBIT 170.31
EV / FCF n/a

Financial Position

Current Ratio n/a
Quick Ratio n/a
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Invested Capital (ROIC) 21.05%
Return on Capital Employed (ROCE) n/a
Weighted Average Cost of Capital (WACC) 6.00%
Revenue Per Employee 1.17M
Profits Per Employee 147,579
Employee Count 1,306
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, HKG:2315 has paid 16.50 million in taxes.

Income Tax 16.50M
Effective Tax Rate 7.89%

Stock Price Statistics

The stock price has increased by +528.88% in the last 52 weeks. The beta is 0.32, so HKG:2315's price volatility has been lower than the market average.

Beta (5Y) 0.32
52-Week Price Change +528.88%
50-Day Moving Average 43.32
200-Day Moving Average 29.20
Relative Strength Index (RSI) 62.25
Average Volume (20 Days) 1,268,404

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, HKG:2315 had revenue of HKD 1.53 billion and earned 192.74 million in profits. Earnings per share was 0.48.

Revenue 1.53B
Gross Profit 1.53B
Operating Income 209.85M
Pretax Income 209.24M
Net Income 192.74M
EBITDA 364.41M
EBIT 209.85M
Earnings Per Share (EPS) 0.48
Full Income Statement

Balance Sheet

Cash & Cash Equivalents n/a
Total Debt n/a
Net Cash n/a
Net Cash Per Share n/a
Equity (Book Value) n/a
Book Value Per Share n/a
Working Capital n/a
Full Balance Sheet

Cash Flow

Operating Cash Flow n/a
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of 13.68% and 12.56%.

Gross Margin 100.00%
Operating Margin 13.68%
Pretax Margin 13.64%
Profit Margin 12.56%
EBITDA Margin 23.75%
EBIT Margin 13.68%
FCF Margin n/a

Dividends & Yields

HKG:2315 does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield 0.31%
Shareholder Yield 0.31%
Earnings Yield 0.54%
FCF Yield n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 2